Cadence™ Single-pass TFF Coupled with Chromatography Steps Enables Continuous Bioprocessing while Reducing Processing Times and Volumes
contributed by Pall Biotech |
Catherine Casey1, M.Sc., Karl Rogler1, Xhorxhi Gjoka1,
René Gantier1, Ph.D., and Engin Ayturk1, Ph.D.,
1BioPharm Applications R&D
Continuous bioprocessing initiatives have accelerated in recent years. The transition from batch to continuous bioprocessing offers numerous advantages, including process time savings and lower capital costs due to smaller equipment, tanks, and tubing sizes. Additionally, hold tanks may no longer be needed between unit operations, which can be especially valuable for facilities with limited manufacturing floor space. Furthermore, reduced system hold-up volumes improve product recoveries and also contribute to the smaller system footprint of continuous bioprocessing systems.
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!